CorMedix (CRMD) Retained Earnings (2010 - 2025)

CorMedix (CRMD) has 15 years of Retained Earnings data on file, last reported at $581.8 million in Q4 2025.

• For the quarter ending Q4 2025, Retained Earnings rose 271.3% year-over-year to $581.8 million; the trailing twelve-month figure through Dec 2025 stood at $581.8 million (up 271.3% YoY), and the FY2025 full-year result was $581.8 million, up 271.3% from the prior year.
• Retained Earnings grew to $581.8 million in Q4 2025, from $564.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $581.8 million in Q4 2025 to a low of -$339.6 million in Q4 2024.
• A 5-year average of $37.6 million and a median of $82583.0 in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings plunged 279834.28% in 2022 and surged 389144.76% in 2024, its largest moves.
• Tracing CRMD's Retained Earnings over 5 years: stood at -$245.7 million in 2021, then fell by 12.09% to -$275.4 million in 2022, then soared by 242.25% to $391.7 million in 2023, then slumped by 186.71% to -$339.6 million in 2024, then surged by 271.3% to $581.8 million in 2025.
• Business Quant data shows CRMD's Retained Earnings at $581.8 million in Q4 2025, $564.6 million in Q3 2025, and $79435.0 in Q2 2025.